Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$623,146.94
% of Total Estimate Gain
22.15%

Thrivent All Cap Portfolio's Merck & Co Inc Holding Summary

As of 2025-03-31, THRIVENT SERIES FUND INC held - shares of Merck & Co Inc(MRK), totaling N/A. This investment constitutes 0% of their stock portfolio, and THRIVENT SERIES FUND INC now holds 0% of the outstanding Merck & Co Inc(MRK) stock.

The initial trade took place in 2020Q1. And since then Thrivent All Cap Portfolio has made 5 purchases of MRK, at an average price of $77.66, for a total of 36,230.00 shares. In addition, there have been 5 sales at an average price of $94.86 for 36,230.00 shares. Based on historical transaction data and MRK's current price of $79.31, Thrivent All Cap Portfolio's estimated gain on his MRK holdings is $623,146.94, reflecting a 22.15% gain to date.

Thrivent All Cap Portfolio MRK ($79.31) Holding Chart

Thrivent All Cap Portfolio MRK ($79.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1